EyeCon 2024: Insights on transforming ocular surface disease management

Commentary
Video

Peter J. McDonnell, MD, and Laura M. Periman, MD, discussed innovations in treating ocular surface conditions, emphasizing patient-centered care and interdisciplinary collaboration.

Peter J. McDonnell, MD, and Laura M. Periman, MD, highlighted advancements in ocular surface disease and its treatment in a discussion at EyeCon 2024, held September 27 and 28, in Fort Lauderdale, Florida,

McDonnell, chief medical editor of sister brand Ophthalmology Times and cochair of EyeCon 2024, emphasized the challenges that clinicians face in integrating new information and technologies into their practices. Periman, who leads the Periman Eye Institute, shared her insights on transforming dry eye management into a specialized practice model, advocating for patient-centered care that prioritizes time and attention over rushed appointments.

They noted that conditions like cataract and refractive surgeries often exacerbate dry eye symptoms, underscoring the need for all practitioners to recognize and address ocular surface disease in their patients. The conversation highlighted that successful patient care relies on effective communication and knowledge sharing across different areas of expertise, particularly at educational platforms like EyeCon, where subspecialists gather to enhance their skills and understanding.

With ongoing challenges such as the increasing prevalence of myopia and age-related macular degeneration, the need for innovative care models is paramount. McDonnell and Periman encouraged attendees to leverage new strategies and insights from the conference to better serve their patients, ensuring that even those focusing on surgical interventions do not overlook the importance of ocular surface health. The dialogue underscored the collective commitment to advancing eye care and improving patient outcomes through continued education and collaboration.

Recent Videos
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
© 2025 MJH Life Sciences

All rights reserved.